Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Acadia Pharmaceuticals
Acadia Pharmaceuticals
(ACAD)
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Nuplazid
Pimavanserin
2016-04-29
2024-2038
Hallucinations
,
Parkinson disease
,
Schizophrenia spectrum and other psychotic disorders
Daybue
Trofinetide
2023-03-10
2032-2040
Rett syndrome
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Pimavanserin
alzheimer disease
,
hallucinations
,
autism spectrum disorder
,
schizophrenia
,
psychotic disorders
,
parkinson disease
,
neurodegenerative diseases
,
sleep initiation and maintenance disorders
,
post-traumatic stress disorders
Trofinetide
rett syndrome
Tartrate
alzheimer disease
,
autism spectrum disorder
,
parkinson disease
Glutamic acid
schizophrenia
,
psychotic disorders
D-glutamate
schizophrenia
,
psychotic disorders
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use